Advertisement

Topics

Fuji Pharma to market Mithra's hormone therapy Donesta in Japan and ASEAN

19:00 EDT 28 Jun 2017 | Pharmaceutical Technology

Belgium-based pharmaceutical company Mithra has signed an exclusive license and supply agreement (LSA) with Japanese firm Fuji Pharma for the commercialisation of Donesta in Japan and Association of South-East Asian Nations (ASEAN) territories.

Original Article: Fuji Pharma to market Mithra's hormone therapy Donesta in Japan and ASEAN

NEXT ARTICLE

More From BioPortfolio on "Fuji Pharma to market Mithra's hormone therapy Donesta in Japan and ASEAN"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...